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In order to compare the prevalence of antibiotic resistance in different geographical
areas, it is necessary to ensure that agreement is achieved between laboratories on
the assignment of strains to 'susceptible' and 'resistant' categories. An international
quality assessment study, involving 15 laboratories in eight countries, was performed
to investigate the standard of performance of the susceptibility testing of
Haemophilus influenzae. One hundred and fifty strains of H. influenzae were
distributed from the London Hospital Medical College (LHMC) to all laboratories
who were asked to test the susceptibility of the strains to ampicillin, chloramphenicol,
tetracycline, trimethoprim, cephalosporins and ciprofloxacin. Laboratories were also
asked to provide the details of methodology to test the susceptibility. Significant
discrepancy between the LHMC and the participating laboratories appeared in the
detection of resistance to ampicillin (especially /J-lactamase-negative strains resistant
to ampicillin) as well as the assignment of susceptibility and resistance to
chloramphenicol, tetracycline and trimethoprim. Often these reflected the use of
inappropriate breakpoints which led to erroneous assignment of susceptibility. Other
variations including disc content, medium and supplement, inoculum as well as
failure to measure zone sizes properly also led to some repeating anomalies.
Introduction
Despite great attention to susceptibility test methods of Haemophilus influenzae,
discrepancies between laboratories in the detection of resistance still exist. Some
discrepancies were due to variation in methods, others were due to variation in
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susceptibility guidelines (Philpott-Howard, Seymour & Williams, 1983; Snell, Brown &
Phua, 1986; Snell, 1994).
A study of//, influenzae susceptibility by Philpott-Howard et al. (1983) involving 25
laboratories in the UK found good agreement between London Hospital Medical
College (LHMC) and participating laboratories in the assignment of almost all
susceptible strains but high discrepancy levels in the assignment of resistance to
ampicillin, tetracycline and trimethoprim. A National External Quality Assessment
Study (NEQAS) organised to investigate the standard of performance of susceptibility
testing with six H. influenzae strains in 417 laboratories in the UK indicated high rates
of error of both the resistant and susceptible strains (Snell et al., 1986).
The present study was organised to assess the ability of laboratories in different
countries to identify susceptible and resistant strains of H. influenzae and to identify
factors affecting the results. Of the 15 laboratories enrolled, six were from the UK, two
from the USA, two from Norway and one each from Greece, Poland, Sweden,
Switzerland and Turkey. Strains for study were selected on the basis of possession of
known mechanisms of resistance. A large number of strains was used in order to 'hide']
resistance within a group of fully susceptible strains. Apart from ampicillin-resistance
in strains not producing /J-lactamase, which are still subject to debate over the level at
which assignment to 'resistant', should be made, all strains could be assigned with some
confidence to a 'susceptible' or 'resistant' category.
Materials and methods
Bacterial strains
One hundred and fifty H. influenzae strains (mixed, with fully-susceptible and those
with known mechanisms of antibiotic resistance) were selected from our 1991 collection
(Powell et al., 1991), and forwarded to participating laboratories on slopes of chocolate
agar. H. influenzae strains ATCC491002 (susceptible), and two ampicillin-resistant
H. influenzae (/?-lactamase-positive, W10311, and -negative, 518),were included for
internal quality assurance.
Test methods in participating laboratories
The participating laboratories were required to perform the susceptibility testing in their
own routine way. The agents tested were ampicillin, chloramphenicol, tetracycline,
trimethoprim, ciprofloxacin and whichever cephalosporins they tested routinely.
Report form and questionnaire
A result sheet with a list of the strains and the six antimicrobial agents, and a
questionnaire on the methods (inoculum size, interpretation, disc content
of antimicrobial agents) accompanied the strains.
Data analysis
All data were entered on to an Apple Macintosh Classic II computer and analysed with
the computer package Statview II. The participants' results, recorded as 'suceptible'
or 'resistant' were regarded as 'in agreement' if the results were the same as those
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of the LHMC and as 'in disagreement' if different. Results recorded as 'intermediate'
were included in the resistant group. The zone diameters measured in the participating
laboratories were also recorded and forwarded to the LHMC for analysis.
Results
Susceptibility test methods used by participating laboratories
The methods used by the 15 participating laboratories are shown in Table I. One
laboratory, laboratory E, used the broth dilution method whereas the others routinely
used disc diffusion tests. Among those laboratories using disc diffusion tests, two used
Stake's method with an H. inftuenzae control strain (laboratories G and H).
Five participating laboratories in the UK used diagnostic sensitivity test agar (DST)
supplemented with either lysed horse blood and NAD or chocolatized horse blood and
isovitalex. In other European countries, supplemented Mueller-Hinton and IsoSensitest
agars were commonly used whereas two laboratories in the USA used supplemented
haemophilus test agar.
All the UK laboratories used discs containing 2/ig ampicillin, 10/zg chloramphenicol,
10/ig tetracycline, but the contents of the trimethoprim, cephalosporins and
ciprofloxacin discs used varied with each laboratory. Higher content ampicillin,
chloramphenicol and tetracycline discs were commonly used in the laboratories outside
the UK.
Techniques for the preparation and estimation of inocula were variable with no two
laboratories following identical procedures.
Table I. Susceptibility testing used by participatants to test H. influenzae isolates
Laboratory
A
B
C
D
E
G
H
I
J
L
M
N
O
P
R
K
Media"
DST
DST
ISA
DST
DST
DST
DST
not stated
ISA
MHA
MHA
HTM
HTM
ISA
ISA
not stated
Supplemented4
LHB + NAD
LHB + NAD
LHB + NAD
LHB + NAD
LHB + NAD
Cho-HB
Cho-HB + isovitalex
—
Haemoglobin +
isovitalex
Cho-HB
Fildes' extract
—
hematin + NAD
LSB + isovitalex
LSB + isovitalex
—
Interpretive
guideline
in-house
in-house
—
BSAC
BSAC
Stokes'
Stokes'
—
Swedish RGA
NCCLS
NCCLS
NCCLS
NCCLS
new standard
new standard
—
Method of
reading
caliper
caliper
—
ruler
—
caliper
ruler
—
caliper
—
ruler
caliper
caliper
caliper
caliper
—
•DST, Diagnostic sensitivity test agar; ISA, IsoSensitest agar, MHA, Mueller-Hinton agar;
HTM, haemophilus test medium.
*LHB, Lysed horse blood; Cho-HB, chocolatized horse blood; LSB, lysed sheep blood.
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Susceptible results for quality control reference strains
Despite variations in inhibition zone diameters recorded by participating laboratories,
categorisation of the susceptibility of the three reference strains of H. influenzae was
generally correct, with the exception of ampicillin against the intrinsically
ampicillin-resistant H. influenzae strains (Table II). Only six laboratories reported these
organisms correctly as resistant, of which five used 2/ig ampicillin discs. A minority of
laboratories reported strain W10311 incorrectly as chloramphenicol and trimethoprim
susceptible and strain 518 as tetracycline and trimethoprim resistant. All these
laboratories used 30/^g discs.
Since different cephalosporins were used by different participating laboratories,
results for these antimicrobials are not shown in Table II. Nevertheless, all laboratories
reported both strains ATCC491002 and W10311 to be cephalosporin-susceptible
whereas variable results were reported with the intrinsically ampicillin-resistant strains
(518). Three laboratories using cefuroxime discs and one using cephalothin discs
reported this strain as showing intermediate resistance, whereas the remainder reported
it as susceptible to either cefuroxime, cefotaxime or ceftriaxone. AJ1 three reference
strains were reported as susceptible to ciprofloxacin by all participating laboratories.
Susceptibility test results recorded at participating laboratories
Although 150 H. influenzae strains were distributed, some isolates were not viable upon
subculture in some laboratories. Consequently, different numbers of strains were tested
at each centre.
Inhibition zone diameters of each antimicrobial agent recorded in participating
centres were plotted on separate histograms. Since laboratory E was using the dilution
method, only the results from the other 14 laboratories were used to plot the histograms.
Susceptibility breakpoints used by all except two participating laboratories for each of
the antimicrobial agents are shown by solid lines. The other two laboratories used
Stokes' method.
Ampicillin
Table III summaries the discrepancies between the LHMC and participating
laboratories in the reporting of susceptibility to ampicillin. Figure 1 shows histograms
depicting the inhibition zones obtained with ampicillin discs from each reporting
laboratory.
For the ampicillin-susceptible strains, eight of the laboratories (B, E, G, H, I, J, L
and N) reported results in full concordance with the LHMC and five others (C, D, M,
O and R) showed only one or two cases of interpretative disagreement. In some
laboratories, for example, laboratory R, two ampicillin-susceptible strains were
recorded as resistant owing to the diminished zone sizes recorded by this laboratory.
The reason for this was unknown but presumably due to inoculum size. Of the
susceptible strains, 54% were reported as intermediate by laboratory P. This is because
the susceptible breakpoint used by this laboratory was >3mm larger than that used
by any of the other laboratories except laboratory J. The fact that so many strains
overall were passed as 'intermediate' in laboratory P was because of the wide separation
of resistant and susceptible breakpoints.
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Laboratories other than I and K, were ;>90% efficient in detecting the resistance of
the /?-lactamase-positive strains. There was however frequent disagreement between the
LHMC and the participating laboratories in the categorisation of strains considered at
the LHMC to have intrinsic resistance to ampicillin. The participating laboratories
reported anywhere from 11% to 100% of these strains as susceptible; laboratories using
lug ampicillin discs reported 11% to 82% as susceptible and those using 10//g reported
23% to 100% as susceptible. Overall, laboratories using 2/ig ampicillin discs were more
likely to detect intrinsic resistance than those using 10/ig discs (P < 0.05).
In some laboratories, apart from disc content, the adoption of inappropriate
breakpoints was responsible for the failure to detect intrinsic resistant. This was
apparent in laboratories B, J and N. For instance, 75% of resistant strains would have
been reported correctly if the susceptibility guidelines of laboratory B were adjusted to
21mm rather than 18mm. For laboratory P, the wide gap between susceptible and
resistant breakpoints resulted in most strains, with or without intrinsic resistance, being
classed as 'intermediate'. Among the other laboratories, the distribution of ampicillin
zones for the ampicillin-susceptible and -resistant strains overlapped.
Chloramphenicol
Seven of the 150 H. influenzae strains were resistant to chloramphenicol and produced
chloramphenicol-acetyltransferase (CAT). Results for chloramphenicol susceptibility
and zone distribution recorded in the participating laboratories are shown in Table IV
and Figure 2. Results reported by eight laboratories were in concordance with the
LHMC and two further laboratories had only one discordant result each. As for the
laboratories which failed to report results in agreement with the LHMC, the adoption
of inappropriate interpretive guidelines was apparent in laboratories K, L, P and R. For
laboratories K, P and R, the breakpoints detected all resistant strains, but the
breakpoints were inappropriate because they also included most of the susceptible
Table IV. Reporting of chloramphenicol susceptibility in each laboratory*
Laboratory
A
B
C
D
E
G
H
I
J
L
M
N
O
P
R
K
Disc content
(MS,)
10
10
10
10
—
10
10
30
30
30
30
30
30
30
30
30
Chloramphenicol-resistant
reported R/I
100 (7)
100(7)
100(7)
100(7)
86(6)
100(7)
100(7)
100(4)
100(7)
17(1)
83(5)
100 (7)
100(7)
100(7)
100(4)
100(7)
reported S
0
0
0
0
14(1)
0
0
0
0
83(5)
17(1)
0
0
0
0
0
Chloramphenicol-sensitive
reported R/I
0
0
0
0
0
0
0
0
0
0
3(3)
1 (1)
0
44(62)
26 (24)
30 (42)
reported S
100 (143)
100 (143)
100(133)
100 (143)
100 (143)
100(138)
100 (141)
100(112)
100(141)
100(132)
97 (119)
99 (141)
100 (142)
56(80)
74(67)
70 (100)
•Other details as in footnote to Table III.
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Figure 1. Inhibition zones (mm) of ampicillin for the central laboratory (Lab. A) and each laboratory. • ,
Ampicillin-susceptible; 0 , ampicillin-resistant, /?-lactamase-positive; D. ampicilhn-resistant, ^-lactamase-
negative.
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strains as susceptible. In laboratory J, a zone diameter of 25mm was adopted as the
breakpoint despite the 26mm zone produced. Laboratories using 30/ig chloramphenicol
discs made significantly more errors, including the false reporting of susceptible and
resistant results, than those using 10//g discs (P < 0.05).
Tetracycline
Discrepancies in reporting tetracycline-susceptibility between the LHMC and the
participants are shown in Table V. Three laboratories reported all results in
concordance with the LHMC, whereas five showed only one or two discordant results.
On average, laboratories using 10/ig discs made significantly fewer errors than those
using 30/ig discs {P < 0.05). Laboratories using supplemented DST agar showed a
significantly lower error rate, including the false reporting of susceptibility and
resistance, than those using other media (P < 0.05). Inappropriate interpretive
guidelines were also apparent in some laboratories, where either resistance was reported
as susceptible or vice versa (Figure 3). Furthermore, the zone sizes produced by some
of the resistant strains overlapped with those of the susceptible strains. This was a
particular problem with laboratories using 30fig discs. Among those using doxycycline,
laboratories P and R detected resistance in all of the strains recorded as resistant by
the LHMC, but greatly overestimated susceptibility amongst those found susceptible
by the LHMC: 74% of which were categorised as intermediate by laboratory P and 89%
of which were reported as intermediate by laboratory R.
Trimethoprim
Table VI shows the susceptibility of trimethoprim reported by participating
laboratories, while the histograms in Figure 4 show the zone distribution.
Table V. Reporting of tetracycline susceptibility in each laboratory*
Laboratory
A
B
C
D
E
G
H
I
J
L
M
N
O*
P*
R*
K
Disc content
0«g)
10
10
10
10
—
10
10
30
30
30
30
30
30
30
30
30
Tetracycline-resistant
reported R/I
100 (19)
90 (17)
100 (19)
90 (17)
100 (19)
94 (17)
100 (18)
85(11)
100 (17)
50(8)
94 (15)
100 (19)
89 (16)
100 (19)
100 (8)
32(6)
reported S
0
10(2)
0
10(2)
0
6(1)
0
15(2)
0
50(8)
6(1)
0
11 (2)
0
0
68 (13)
Tetracycline-sensitive
reported R/I
0
0
0
0
1 (1)
0
0
0
0
0
15(17)
13(17)
8(10)
74 (96)
89 (77)
2(2)
reported S
100 (131)
100 (131)
100 (121)
100 (131)
99 (130)
100 (127)
100 (130)
100 (103)
100 (131)
100 (122)
85 (95)
87 (113)
92 (121)
26 (34)
11 (10)
98 (128)
•Other details as in footnote to Table III.
'Doxycycline was used.
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Table VI. Reporting of trimethoprim susceptibility in each laboratory*
Disc content Trimethoprim-resistant Trimethoprim-sensitive
Laboratory Medium* (jig) reported R/I reported S reported R/I reported S
A
B
C
D
E
G
H
I
J
L
M
N
0
P
R
K
DST'
DST'
ISA'
DST'
DST'
DST'
DST'
NS
ISA
MHA'
MHA
HTM
HTM
ISA'
ISA'
NS
1.25
2.5
2.5
1.25
—
2.5
2.5
1.25
5
5
1.25
1.25
1.25
2.5
5
1.25
100 (47)
85 (40)
80 (36)
89 (42)
100 (47)
93 (42)
98 (45)
90 (37)
89 (42)
80 (35)
27(11)
85 (40)
89 (42)
98 (46)
90 (29)
66 (31)
0 0
15(7)
20(9)
10(5)
0 0
7(3)
2(1)
10(4)
11 (5)
20(9)
73 (30)
15(7)
11 (5)
2(1)
10(3)
34 (16)
0 0
0 0
0 0
1 (1)
3(3)
1 (1)
0 0
0 0
0 0
0 0
0 0
o 0
0 0
72 (73)
10(6)
1 (1)
100 (103)
100 (103)
100 (95)
99 (102)
97 (100)
99(99)
100 (102)
100 (75)
100(101)
100 (94)
100 (87)
100 (102)
100 (102)
28 (29)
90 (57)
99 (101)
"Other details as in footnote to Table III.
*See Table I for the abbreviations; NS, not stated.
'Added lysed blood.
Despite the fact that laboratories using DST agar supplemented with lysed horse
blood gave significantly better results in the detection of resistance than those using
other media (P < 0.05), some of the discrepancies could be attributed to the use of
inappropriate breakpoints. This was apparent in laboratories B, M and K where ;> 15%
of the resistant strains were reported as susceptible. Although most of the laboratories
reported the susceptible strains correctly, 73/102 of thetrimethoprim-susceptible strains
were misreported by laboratory P.
Cephalosporins
Despite the varieties of cephalosporins and disc contents tested, there was a constant
pattern of mean inhibition zone sizes recorded with cephalosporin discs at nine
participating laboratories: inhibition zone sizes for intrinsically ampicillin-resistant
strains were significantly smaller than those for the ampicillin-susceptible and
/?-lactamase-producing strains (/* < 0.01). Among these laboratories, six used
cefuroxime, two used cefotaxime and one cephalothin. Nevertheless, there was always
some overlap between the zones for the ampicillin-susceptible and intrinsically
ampicillin-resistant strains. This overlap was least prominent in four laboratories (B,
G, H and J) using cefuroxime, but tended to be greater in laboratories using cefotaxime,
ceftriaxone and cefalothin discs (Figure 5).
Ciproftoxacin
Figure 6 shows the wide variation in the distribution of inhibition zone sizes even when
the same disc content was used. The modal MIC of ciprofloxacin was 0.015mg/L, all
strains were inhibited by ^0.06mg/L of this antimicrobial agent, and all were assumed
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to be susceptible by the LHMC. However, disc testing at the LHMC showed that three
strains gave zone sizes of < 33mm compared to a modal zone size of 39mm for all other
strains. All participating laboratories reported these strains as susceptible even though
reduced zone sizes were also recorded by them.
Discussion
It is apparent that susceptible and resistant strains will not be distinguished by a
laboratory if either (a) the zone distribution for the groups of strains overlap, or (b)
if the breakpoints used are inappropriate. Factors which may result in zones of
susceptible and resistant strains overlapping in one laboratory but not in another
included the inoculum size, the medium, the disc strenth, the incubation conditions and
the accuracy with which the zones were measured.
Many sources of inter-laboratory variation in the detection of resistance can be
identified, but, since no laboratories followed identical procedures, the identification of
single factor responsible for causing erroneous results is difficult. The inoculum size is
one factor. Inoculum size, although not specifically evaluated in the present study, is
particularly important when testing susceptibility of H. influenzae. Inoculum density
is critical if reproducible results are to be obtained. Most workers standardise the
inoculum by "experience" and "judgement". Although comparison with McFarland
standard is usually recommended, Lapointe & Lavallee (1987) noted a wide range of
colony counts when the turbidity of bacterial suspensions were adjusted to match a 0.5
McFarland standard. Fernandes et al. (1987) also demonstrated significant problems
in standardising the inoculum by adjusting a bacterial suspension visually to match a
McFarland turbidity standard, and small changes in inoculum size may alter the zone
diameters by at least 3—4mm. It is important, therefore, to adjust the inoculum carefully
to allow high reproducibility.
Although the measurement of zone diameters appears to be an easy task, it is a
potential source of error and may affect the final interpretation of results. In the present
study, some laboratories only recorded even numbered zone diameters. Apparently the
zone radius was measured and doubled. This is inherently inaccurate since the centre
of the disc must be judged. Moreover, any errors in measurement of radii are doubled
when these values are converted into diameters.
Despite the fact that many laboratories claimed to follow recommended
methodologies and interpretive guidelines, e.g. NCCLS, some clearly failed to perform
susceptibility testing in accordance with the methods and guidelines described. For
example, laboratory L, although claiming to use the NCCLS methods, had quoted
different breakpoints to laboratories M, N and O, which also claimed to use these
methods. Since the susceptibility testing of H. influenzae is highly method-dependent,
using only the recommended or prescribed breakpoint is unsatisfactory, the
methodology must be followed in full.
Misreporting of susceptibility and resistance was common, even when zones for
groups of strains were clearly distinguished as was, for example, generally the case with
ampicillin, chloramphenicol, tetracycline and trimethoprim. These reflected the use of
inappropriate breakpoints. Ideally, interpretive breakpoints should aim to separate the
normal susceptible from the insusceptible or resistant populations. Results observed in
the present study showed that, in many cases, despite the resistant and susceptible
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populations having been clearly distinguished, some of the strains were reported
wrongly because of an inappropriate breakpoint. Categorisation could in many cases
be improved considerably if the breakpoints were adjusted to accomodate the local
results. Since different methods were used in each laboratory, it would be better to
decide the interpretive breakpoint by looking at their own results where the most
appropriate cut-off occurs to distinguish the susceptible and resistant strains.
Only a few laboratories failed to identify ampicillin-susceptible and /Mactamase-
positive H. influenzae. However, discrepancies between the LHMC and participating
laboratories arose frequently with regard to the intrinsically ampicillin-resistant strains.
The use of 2/ig ampicillin discs more readily identified intrinsic ampicillin-resistance
than did the 10/ig discs. These results agree with those reported by Doern, Daum &
Tubert (1987) and Powell & Williams (1988).
Failure to detect chloramphenicol resistance is often reported (Philpott-Howard
et al., 1983; Snell, Perry & Brown, 1991; Snell, 1994). They observed that failure to
detect chloramphenicol resistance by disc diffusion methods was quite common, but that
error rates were minimised by the use of low content discs (10/ig). The results in the
present study are in agreement with the findings of these authors, namely that the
accurate detection of chloramphenicol resistance is faciliated by the use of low content
(10/ig) rather than higher content discs (30/ig) (P < 0.05).
Philpott-Howard et al. (1983) noted that the detection of resistance to tetracycline
was influenced by the medium used, whereas no association between disc content and
detection of tetracycline resistance was established. The present study, however, showed
both the use of DST agar and low content discs were associated with more accurate
results (P < 0.05).
In a NEQAS survey, Snell (1994) revealed a 19% error rate of laboratories in
detecting the susceptibility of H. influenzae to trimethoprim. In the present study, error
rates ranged from 1% to 30% for the detection of resistant strains and 1% to 73% for
susceptible strains. The present study showed that significantly more correct results were
obtained by laboratories using DST agar supplemented with lysed blood than those
using other media (P < 0.05).
Mean inhibition zone sizes of some cephalosporins discs were significantly
reduced for intrinsically ampicillin-resistant strains compared with those for ampicillin-
susceptible and /J-lactamase-positive strains. This was particularly apparent when
cefuroxime was used. Cefuroxime discs may, perhaps, provide a useful indication for
the detection of intrinsic resistance to ampicillin.
Distribution of inhibition zone diameters around ciprofloxacin discs varied
considerably with each of the participating laboratories. However, laboratories using
1/ig and 5/ig discs reported smaller and normal distribution of zones than those using
10/ig discs. Although no ciprofloxacin-resistant strains were available to include in this
exercise, three strains against which the MICs were low, nevertheless gave small zone
sizes. These require further study.
In conclusion, problems still exist in many countries in the performance of
susceptibility testing of H. influenzae. Most of the errors found were associated with
the failure to assign the strains correctly. Considerable reduction in some of these error
rates could be achieved simply by changing the methodology or adjusting the
interpretive breakpoints. Recommendation, based upon this study and also on previous
studies (Philpott-Howard et al., 1983; Snell et al., 1986) are: (1) it is unnecessary for
all laboratories to perform the tests in the same way but tests need to be performed
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in a reproducible manner. (2) The methods should be capable of differentiating
accurately between susceptible and resistant strains. (3) Lower content antibiotic discs
should be used. (4) Inocula should be made in a manner to allow high reproducibility.
(5) Zone diameters should be measured precisely. (6) If a particular system for
antimicrobial susceptibility testing is adopted this cannot be confined to interpretive
breakpoints, but the prescribed methodology has to be precisely followed. (7)
Interpretive breakpoints can be generated by the techniques employed in an individual
laboratory and not solely based upon tabulated guidelines since different methods are
used in each laboratory.
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